Publications
5677 Results
- Journal / Conference
- JAMA Oncology Aug 1;9(8):1083-1089
- Year
- 2023
- Research Committee(s)
- Breast
- PMID
- PMID37410451
- PMC
- PMC10326730
- Study Number(s)
- S1007
Radiotherapy Use and Incidence of Locoregional Recurrence in Patients with Favorable-Risk Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial
- Journal / Conference
- Nature Medicine Jun;29(6):1412-1423
- Year
- 2023
- Research Committee(s)
- Cancer Control, Prevention, Screening, and and Surveillance
- PMID
- PMID37264206
- PMC
- PMC10287565
- Study Number(s)
- S0000, SWOG-9217
Genetically Adjusted PSA Levels for Prostate Cancer Screening
- Journal / Conference
- JCO Oncology Practice Aug;19(8):533-535
- Year
- 2023
- PMID
- PMID37285550
- PMC
- PMC10424897
Crisis of the clinical trials staff attrition following the COVID-19 pandemic [Editorial]
- Journal / Conference
- ANNALS OF SURGICAL ONCOLOGY
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID36542251
- Study Number(s)
- S0809
ASO Visual Abstract: Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers - Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
- Journal / Conference
- Lancet Apr 15;401(10384):1277-1292
- Year
- 2023
- Research Committee(s)
- Breast
- PMID
- PMID37061269
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100,000 women from 86 randomised trials. Early Breast Cancer Trialists’ Collaborative Group [SWOG collaborators GT Budd, W Barlow, K Albain, J Gralow, D Hayes, R Jagsi]
- Journal / Conference
- British Journal of Cancer Aug;129(3):511-520
- Year
- 2023
- Research Committee(s)
- Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID37365285
- PMC
- PMC10403521
- Study Number(s)
- S0000
Probing the diabetes and colorectal cancer relationship using gene – environment interaction analyses
- Journal / Conference
- Cancer Epidemiology, Biomarkers & Prevention Sep 1;32(9):1265-1269
- Year
- 2023
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID37351909
- PMC
- PMC10529823
- Study Number(s)
- S0000
Genetic susceptibility to nonalcoholic fatty liver disease and risk for pancreatic cancer: Mendelian randomization
- Journal / Conference
- Gynecologic Oncology Jun;173:130-137
- Year
- 2023
- Research Committee(s)
- Gynecologic
- PMID
- PMID37148580
- PMC
- PMC10414765
- Study Number(s)
- G0182
The effect of old age treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG Oncology Group/Gynecologic Oncology Group study
- Journal / Conference
- Lancet Sep 23;402(10407):1043-1051
- Year
- 2023
- Research Committee(s)
- Genitourinary
- PMID
- PMID37524096
- PMC
- PMC10622111
- Study Number(s)
- S0931
Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial
- Journal / Conference
- Cancers (Basel) Apr 29;15(9):2561
- Year
- 2023
- Research Committee(s)
- Melanoma
- PMID
- PMID37174027
- PMC
- PMC10177189
- Study Number(s)
- CTSU/E1609, S1404